Samsca (tolvaptan)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Samsca (tolvaptan), covering 2012-05-03 to 2024-11-20. Get the full timeline:
Most recent: Clinical Trial Update: Acute Heart Failure Patients With High Copeptin Treated With Tolvaptan Targets Increased AVP Activation for Treatment (ACTIVATE) [Phase 3]